- ￥1480
- TargetMol
- 美国
- T62858
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
hGPR91 antagonist 3
- 库存：
10
- 供应商：
TargetMol
- CAS号：
1314796-31-0
- 规格：
1 mg
Product Introduction
Bioactivity
英文名:hGPR91 antagonist 3
描述:hGPR91 antagonist 3 is an orally active, potent, and selective hGPR91 antagonist. hGPR91 antagonist 3 is used to study hypertension, autoimmune diseases, and retinal angiogenesis. hGPR91 antagonist 3 has been shown to be effective in the treatment of hypertension, autoimmune disease, and retinal angiogenesis.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Characterization of 5‐HT1A,B and 5‐HT2A,C Serotonin Receptor Binding
, which for this experiment were 249 fmol/mg protein, 0.56 nM, and 0.91, respectively. The dashed line without data points represents specific binding calculated using the values of parameters Bmax , KD , and slope factor.
Saturation Assays of Radioligand Binding to Receptors and Their Allosteric Modulatory Sites
. The binding of ligands (e.g., the agonist muscimol and antagonist bicuculline) to the GABA receptor requires both α and β subunits. Similarly, both α and γ subunits are required for optimal binding of the agonist diazepam and the antagonist flumazenil
Practical Aspects of Radioligand Binding
Figure 1.3.3 Competition between a radiolabeled antagonist and an unlabeled agonist for muscarinic receptors on N1E‐115 cells. [3 H]Quinuclidinyl benzilate ([3 H]QNB; 0.2 nM) was incubated with 200,000 intact cells/tube and various concentrations
技术资料暂无技术资料 索取技术资料
